Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

In this multinational observational study involving patients hospitalized with Covid-19, we confirmed previous observations suggesting that underlying cardiovascular disease is independently associated with an increased risk of in-hospital death. We were not able to confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with in-hospital mortality in this clinical context.

https://www.nejm.org/doi/full/10.1056/NEJMoa2007621?query=C19